Optiprost Mini Eye Drop contains Bimatoprost 0.01% w/v, a prostaglandin analog used to lower elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension. Its low-strength formulation ensures effective pressure control with improved tolerability.
The eye drop works by increasing the outflow of aqueous humor, helping to maintain healthy eye pressure levels and protect the optic nerve, supporting long-term visual health.
From a franchise perspective, Optiprost Mini Eye Drop is a high-demand anti-glaucoma ophthalmic product, widely prescribed in eye hospitals, ophthalmology clinics, and specialty centers, ensuring consistent prescriptions and repeat sales.
Adding Optiprost Mini Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma segment, offering long-term growth, strong prescriber trust, and enhanced portfolio credibility for PCD pharma franchise partners.
Common side effects may include eye redness, mild itching, burning sensation, foreign body sensation, or increased eyelash growth. Rarely, changes in iris pigmentation, eyelid darkening, or blurred vision may occur with prolonged use.
Optiprost Mini Eye Drop is indicated for the treatment of open-angle glaucoma and ocular hypertension. It is used to reduce elevated intraocular pressure and help prevent optic nerve damage under ophthalmologist supervision.
Use Optiprost Mini Eye Drop strictly as prescribed by an ophthalmologist. Avoid contact between the dropper tip and the eye to prevent contamination. Remove contact lenses before use and reinsert after the advised interval. Inform your doctor if you notice changes in eye color, eyelids, or vision.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.